214 related articles for article (PubMed ID: 12511928)
1. Malaria--there could be a third way.
Miles MA
Nature; 2003 Jan; 421(6918):13. PubMed ID: 12511928
[No Abstract] [Full Text] [Related]
2. Medicine: knockout malaria vaccine?
Ménard R
Nature; 2005 Jan; 433(7022):113-4. PubMed ID: 15650722
[No Abstract] [Full Text] [Related]
3. Arrest in the liver--a genetically defined malaria vaccine?
Frevert U; Nardin E
N Engl J Med; 2005 Apr; 352(15):1600-2. PubMed ID: 15829544
[No Abstract] [Full Text] [Related]
4. Genetic engineering of attenuated malaria parasites for vaccination.
Khan SM; Janse CJ; Kappe SH; Mikolajczak SA
Curr Opin Biotechnol; 2012 Dec; 23(6):908-16. PubMed ID: 22560204
[TBL] [Abstract][Full Text] [Related]
5. Towards a blood-stage vaccine for malaria: are we following all the leads?
Good MF
Nat Rev Immunol; 2001 Nov; 1(2):117-25. PubMed ID: 11905819
[TBL] [Abstract][Full Text] [Related]
6. Genetically modified Plasmodium highlights the potential of whole parasite vaccine strategies.
Good MF
Trends Immunol; 2005 Jun; 26(6):295-7. PubMed ID: 15922944
[TBL] [Abstract][Full Text] [Related]
7. In silico identification of genetically attenuated vaccine candidate genes for Plasmodium liver stage.
Kumar H; Frischknecht F; Mair GR; Gomes J
Infect Genet Evol; 2015 Dec; 36():72-81. PubMed ID: 26348884
[TBL] [Abstract][Full Text] [Related]
8. Disarming the malaria parasite.
Engwerda CR; Good MF
Nat Med; 2008 Sep; 14(9):912-3. PubMed ID: 18776880
[No Abstract] [Full Text] [Related]
9. Immune evasion by malaria parasites: a challenge for vaccine development.
Casares S; Richie TL
Curr Opin Immunol; 2009 Jun; 21(3):321-30. PubMed ID: 19493666
[TBL] [Abstract][Full Text] [Related]
10. Vaccine development against malaria.
Matuschewski K
Curr Opin Immunol; 2006 Aug; 18(4):449-57. PubMed ID: 16765576
[TBL] [Abstract][Full Text] [Related]
11. Harnessing immune responses against Plasmodium for rational vaccine design.
Douradinha B; Doolan DL
Trends Parasitol; 2011 Jun; 27(6):274-83. PubMed ID: 21531627
[TBL] [Abstract][Full Text] [Related]
12. Genetically modified Plasmodium parasites as a protective experimental malaria vaccine.
Mueller AK; Labaied M; Kappe SH; Matuschewski K
Nature; 2005 Jan; 433(7022):164-7. PubMed ID: 15580261
[TBL] [Abstract][Full Text] [Related]
13. Vaccines: The take-home lesson.
DeWeerdt S
Nature; 2012 Apr; 484(7395):S24-5. PubMed ID: 22534529
[No Abstract] [Full Text] [Related]
14. Pre-erythrocytic stage malaria vaccines: time for a change in path.
Druilhe P; Barnwell JW
Curr Opin Microbiol; 2007 Aug; 10(4):371-8. PubMed ID: 17709281
[TBL] [Abstract][Full Text] [Related]
15. [Proteomic analysis of Plasmodium, the causal agent of Malaria].
Castro R I; Rodríguez G Mdel C
Salud Publica Mex; 2009; 51 Suppl 3():S395-402. PubMed ID: 20464213
[TBL] [Abstract][Full Text] [Related]
16. Preerythrocytic malaria vaccine development.
Mikolajczak SA; Aly AS; Kappe SH
Curr Opin Infect Dis; 2007 Oct; 20(5):461-6. PubMed ID: 17762778
[TBL] [Abstract][Full Text] [Related]
17. Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes.
Trimnell A; Takagi A; Gupta M; Richie TL; Kappe SH; Wang R
J Immunol; 2009 Nov; 183(9):5870-8. PubMed ID: 19812194
[TBL] [Abstract][Full Text] [Related]
18. DNA vaccination.
Hedstrom RC; Doolan DL
Methods Mol Med; 2002; 72():347-59. PubMed ID: 12125131
[No Abstract] [Full Text] [Related]
19. Time for Genome Editing: Next-Generation Attenuated Malaria Parasites.
Singer M; Frischknecht F
Trends Parasitol; 2017 Mar; 33(3):202-213. PubMed ID: 27793562
[TBL] [Abstract][Full Text] [Related]
20. Interactions between malaria parasites and the host immune system.
Engwerda CR; Good MF
Curr Opin Immunol; 2005 Aug; 17(4):381-7. PubMed ID: 15950450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
